Cargando…

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

BACKGROUND: Circulating tumor cells (CTCs) are an established prognostic marker in castration-resistant prostate cancer but have received little attention in localized high-risk disease. We studied the detection rate of CTCs in patients with high-risk prostate cancer before and after androgen depriv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zapatero, Almudena, Gómez-Caamaño, Antonio, Cabeza Rodriguez, María Ángeles, Muinelo-Romay, Laura, Martin de Vidales, Carmen, Abalo, Alicia, Calvo Crespo, Patricia, Leon Mateos, Luis, Olivier, Carlos, Vega Piris, Lorena Vega
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268302/ https://www.ncbi.nlm.nih.gov/pubmed/32487218 http://dx.doi.org/10.1186/s13014-020-01577-5

Ejemplares similares

Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients
por: León-Mateos, Luis, et al.
Publicado: (2017)

Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022)

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
por: León-Mateos, Luis, et al.
Publicado: (2020)

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
por: León-Mateos, Luis, et al.
Publicado: (2016)

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab
por: Mondelo‐Macía, Patricia, et al.
Publicado: (2021)

Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges
por: Herrero, Carolina, et al.
Publicado: (2020)

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
por: Muinelo-Romay, Laura, et al.
Publicado: (2014)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers
por: Brozos-Vázquez, E. M., et al.
Publicado: (2023)

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer
por: Abreu, Manuel, et al.
Publicado: (2020)

Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
por: Costa, Clotilde, et al.
Publicado: (2020)

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer
por: Mariscal, Javier, et al.
Publicado: (2016)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2020)

Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model
por: López-Cortés, Rubén, et al.
Publicado: (2022)

Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Circulating Free DNA and Its Emerging Role in Autoimmune Diseases
por: Mondelo-Macía, Patricia, et al.
Publicado: (2021)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer
por: Muinelo-Romay, Laura, et al.
Publicado: (2011)

Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells
por: López-Cortés, Rubén, et al.
Publicado: (2023)

Detection of circulating melanoma cells in choroidal melanocytic lesions
por: Bande, Manuel F., et al.
Publicado: (2015)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Association of Salivary Human Papillomavirus Infection and Oral and Oropharyngeal Cancer: A Meta-Analysis
por: Rapado-González, Óscar, et al.
Publicado: (2020)

Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
por: Rodriguez-Casanova, Aitor, et al.
Publicado: (2021)

HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device
por: Lopes, Cláudia, et al.
Publicado: (2021)

Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients
por: Ribeiro-Samy, Silvina, et al.
Publicado: (2019)

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
por: Mondelo-Macía, Patricia, et al.
Publicado: (2021)

Integrity and quantity of salivary cell‐free DNA as a potential molecular biomarker in oral cancer: A preliminary study
por: Rapado‐González, Óscar, et al.
Publicado: (2022)

Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
por: Abreu, Manuel, et al.
Publicado: (2020)

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018)

Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment
por: Piñeiro-Pérez, Raquel, et al.
Publicado: (2022)

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study
por: Vidal Insua, Yolanda, et al.
Publicado: (2017)

Performance of Bioelectrical Impedance and Anthropometric Predictive Equations for Estimation of Muscle Mass in Chronic Kidney Disease Patients
por: Bellafronte, Natália Tomborelli, et al.
Publicado: (2021)

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer
por: Rodríguez-Casanova, Aitor, et al.
Publicado: (2021)

The Impact of COVID-19 on Mortality in Spain: Monitoring Excess Mortality (MoMo) and the Surveillance of Confirmed COVID-19 Deaths
por: León-Gómez, Inmaculada, et al.
Publicado: (2021)

Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report
por: Casas-Arozamena, Carlos, et al.
Publicado: (2022)

Low COVID-19 mortality in Spanish children
por: Tagarro, Alfredo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vk1s1o8otp3kj5dvsp8ftmqd5